Results 21 to 30 of about 1,262,812 (350)
Pneumonia, 2015 Thioredoxin 1 (Trx1) and haptoglobin (Hp) are known to be involved in pathophysiology. This study was conducted to evaluate their diagnostic significance.
Mee-Kyung Cha, Il-Han Kim
doaj +1 more source
Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
Pneumonia, 2023 Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in ...
Salini Mohanty +6 more
doaj +1 more source
Pneumonia, 2022 Background Pneumonia is an acute respiratory infection of the lungs. A child dies of pneumonia every 39 s globally. Even though pneumonia affects children worldwide, the risk and repercussions of the disease are more prevalent in poor and middle-income ...
Tsega-Ab Abebaw +2 more
doaj +1 more source
Viral pneumonia in adults and older children in sub-Saharan Africa — epidemiology, aetiology, diagnosis and management [PDF]
, 2014 Community-acquired pneumonia causes substantial morbidity and mortality in sub-Saharan Africa with an estimated 131 million new cases each year. Viruses — such as influenza virus, respiratory syncytial virus and parainfluenza virus — are now recognised ...
Ho, Antonia
core +2 more sources
Chlamydophila pneumoniae [PDF]
Clinical Microbiology and Infection, 2009 Chlamydophila pneumoniae infection is ubiquitous. It accounts for 10% of community-acquired pneumonias and 5% of cases of pharyngitis, bronchitis and sinusitis in both immunocompetent and immunocompromised hosts. It is also involved in exacerbations of chronic bronchitis and asthma. Moreover, C.
F. Blasi, P. Tarsia, S. Aliberti
openaire +4 more sources
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia. [PDF]
, 2019 IntroductionPneumonia is an important cause of morbidity and mortality in persons living with human immunodeficiency virus (HIV) infection. How immune activation differs among HIV-infected and HIV-uninfected adults with pneumonia is unknown.MethodsThe ...
Byanyima, Patrick +16 more
core +2 more sources
How low can we go? The implications of low bacterial load in respiratory microbiota studies
Pneumonia, 2018 Background Culture-independent sequencing methods are increasingly used to investigate the microbiota associated with human mucosal surfaces, including sites that have low bacterial load in healthy individuals (e.g. the lungs).
Robyn L. Marsh +6 more
doaj +1 more source
Journal of the Belgian Society of Radiology, 2012 Background: A 55-year-old male smoker (60 pack-years) presented to the emergency department with the complaint of high fever and cough for two days. His medical history revealed that he had seizures for ten years and was been suffering from Parkinson’s disease for 3 years. On physi - cal examination he was tachypneic and febrile.
Köhne, Rabia +2 more
openaire +9 more sources
Effect of case management on neonatal mortality due to sepsis and pneumonia. [PDF]
, 2011 BACKGROUND: Each year almost one million newborns die from infections, mostly in low-income countries. Timely case management would save many lives but the relative mortality effect of varying strategies is unknown.
Bhutta, Zulfiqar A +7 more
core +1 more source
Pneumonia, 2023 Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more broadly ...
Eileen M. Dunne +4 more
doaj +1 more source